Tracking COVID-19 in High-Risk Workers
- Gather COVID-19 data from healthcare personnel, first responders, and frontline workers
- Vaccine effectiveness, illness characterization, infection rates, and KAP toward COVID-19 vaccines
- Three COVID-19 vaccine doses are more effective than two doses.
CDC needs timely information on COVID-19 illness characterization and vaccine effectiveness in this highly exposed cohort. CDC also needs data on rates of symptomatic and asymptomatic infection and re-infection. Since this population was among the first to receive COVID-19 vaccines, CDC used the platform to produce estimates of COVID-19 vaccine effectiveness in real-world conditions and continues to update those estimates as new variants emerge. Setting up the infrastructure for gathering the data and then collecting it must be done rapidly to inform policy decisions.
The Research on the Epidemiology of SARS-CoV-2 in Essential Response Personnel (RECOVER) study is a prospective, longitudinal cohort study of approximately 3,500 healthcare personnel, first responders, and frontline workers from six U.S. regions. Abt adapted our existing infrastructures, study protocols, and tools to conduct surveillance activities to assess risk and characterize disease epidemiology of COVID-19. We are partnering with clinical institutions chosen for their history of conducting respiratory virus research. As part of this effort, our study participants have been self-collecting a respiratory specimen every week for more than two years.
Results are ongoing. More information about the study and findings to date can be found below:
- COVID-19 Vaccine Perceptions and Uptake in a National Prospective Cohort of Essential Workers
- High Burden of COVID-19 among Unvaccinated Law Enforcement Officers and Fire Fighters
- Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines
- Abt Partners With CDC on NEJM Study Showing COVID-19 Vaccines Effective At Preventing and Moderating Effects of Infections
- CDC Study: COVID Vaccines Are Effective
- CDC COVID-19 Research Studies